• Home
  • Media
  • Press Releases

Press Releases

Gulf Pharmaceutical Industries (Julphar) launches AED 500 million rights issue

2020-06-01
- Rights issue is part of Julphar's capital restructuring to improve the capital base and debt profile. - The company will offer 500 million new shares with a nominal value of AED 1. Ras Al Khaimah, UAE; June 1, 2020: Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, announced today the launch of its AED 500 million rights issue as the company progresses on its ambitious turnaround plan. The rights issue is set to improve the company’s capital position and debt profile and will provide the financial foundation for the successful implementation of the company’s medium-term growth strategy.

Julphar resumes sales of products in KSA

2020-04-30
After an inspection of Julphar facilities, Saudi Food and Drug Authority has lifted the temporary suspension on the export of Julphar products to Saudi Arabia

Julphar’s Shareholders Approve Capital Restructuring

2020-04-12
Capital reduction, followed by an up to AED 500 million rights issue, will extinguish accumulated losses and is part of a comprehensive transformation programme

Julphar appoints new CEO to drive operational transformation and fuel growth

2020-04-05
Newly appointed Julphar Chief Executive Officer set to deliver new strategic focus for regional pharmaceutical giant   Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.